Untitled 1
Abilify Getting off Abilify and getting rid of the Abilify side
effects can be accomplished. The agitation, anxiety, insomnia and other symptoms
can be reduced greatly or completely eliminated. Abilify and other antipsychotic
medications are known to cause diabetes. There is a solution. Get your patients
the book How to Get Off Psychoactive Drugs Safely and start living a more
complete life quickly.
Click here to go to Amazon.com.
Abilify
Below you will find current clinical studies on Abilify
Aripiprazole Add-On Treatment in a Patient with
Schizoaffective Disorder: Neurocognitive Outcomes.
Pfaffenberger N, Hoertnagl C, Fleischhacker WW, Hofer A.
Pharmacopsychiatry .
2010 May 25. [Epub ahead of print] No abstract available.
Abilify: 20503152 [Abilify - as supplied by publisher] Related
Abilify Citations
Effectiveness of switching from aripiprazole to
ziprasidone in patients with schizophrenia.
Kim SW, Shin IS, Kim JM, Bae
KY
Clin Neuropharmacol .
2010 May;33(3):121-5. Abilify: 20502130
[Abilify - in process] Related
Abilify Citations
Metabolic parameters in patients treated with
olanzapine or other atypical antipsychotics.
Osuntokun OO, Millen B, Xu WI, Kryzhanovskaya LA, Robertson-Plouch C, Carlson
JL, Acharya N, Corya SA.
J Psychopharmacol .
2010 May 24. [Epub ahead of print] Abilify:
20498135 [Abilify - as supplied by publisher] Related
Abilify Citations
Efficacy and tolerability of paliperidone ER and
other oral atypical antipsychotics in schizophrenia.
Jones MP, Nicholl D, Trakas K.
Int J Clin Pharmacol
Ther .
2010 Jun;48(6):383-99. Abilify: 20497747
[Abilify - in process] Related
Abilify Citations
Treatment of schizophreniform disorder by
aripiprazole in a female adolescent with 22q11.2 deletion syndrome.
Lin CE, Hwang KS , Hsieh PH,
Chia-Hsing, Tzeng NS .
Prog
Neuropsychopharmacol Biol Psychiatry . 2010 May 18. [Epub ahead
of print] No abstract available.
Abilify: 20493229
[Abilify - as supplied by publisher] Related
Abilify Citations
Tardive dystonia due to aripiprazole use in a
neuroleptic-naive patient.
Friedman JH.
J Clin Psychiatry .
2010 May;71(5):652-3. No abstract available.
Abilify: 20492857 [Abilify - in process] Related
Abilify Citations
Metabolic syndrome in patients enrolled in a
clinical trial of aripiprazole in the maintenance treatment of bipolar I
disorder: a post hoc analysis of a randomized, double-blind, placebo-controlled
trial.
Kemp DE, Calabrese JR, Tran QV, Pikalov A, Eudicone JM, Baker RA.
J Clin Psychiatry .
2010 May 4. [Epub ahead of print] Abilify:
20492838 [Abilify - as supplied by publisher] Related
Abilify Citations
[Action of amygdala dopamine and effect of
antipsychotics]
Oshibuchi H, Inada K, Ishigooka J.
Nihon Shinkei
Seishin Yakurigaku Zasshi .
2010 Apr;30(2):93-9. Japanese.
Abilify: 20491283 [Abilify - in process] Related
Abilify Citations
Medications Acting on the Dopaminergic System in the
Treatment of Alcoholic Patients.
Swift R.
Curr Pharm Des .
2010 May 20. [Epub ahead of print] Abilify:
20482513 [Abilify - as supplied by publisher] Related
Abilify Citations
A pooled MADRS/IDS cross-correlation analysis:
clinician and patient self-report assessment of improvement in core depressive
symptoms with adjunctive aripiprazole.
Reimherr FW, Martin ML, Eudicone JM, Marchant BK, Tran QV, Pikalov A, Marcus RN,
Berman RM, Carlson BX.
J Clin
Psychopharmacol .
2010 Jun;30(3):300-5. Abilify: 20473067
[Abilify - in process] Related
Abilify Citations
Influence of DAOA gene variants on antipsychotic
response after switch to aripiprazole.
Pae CU, Chiesa A, Serretti A.
Psychiatry Res .
2010 May 12. [Epub ahead of print] Abilify:
20471098 [Abilify - as supplied by publisher] Related
Abilify Citations
Antipsychotics in pregnancy.
McCauley-Elsom K, Gurvich C, Elsom SJ, Kulkarni J.
J Psychiatr Ment
Health Nurs .
2010 Mar;17(2):97-104. Abilify: 20465753
[Abilify - in process] Related
Abilify Citations
Haloperidol, spiperone, pimozide and aripiprazole
reduce intracellular dopamine content in PC12 cells and rat mesencephalic
cultures: Implication of inhibition of vesicular transport.
Matsuo T, Izumi Y, Wakita S, Kume T, Takada-Takatori Y, Sawada H, Akaike A.
Eur J Pharmacol .
2010 May 9. [Epub ahead of print] Abilify:
20460122 [Abilify - as supplied by publisher] Related
Abilify Citations
Effects of adjunctive treatment with aripiprazole on
body weight and clinical efficacy in schizophrenia patients treated with
clozapine: a randomized, double-blind, placebo-controlled trial.
Fleischhacker WW, Heikkinen ME, Olié JP, Landsberg W, Dewaele P, McQuade RD,
Loze JY, Hennicken D, Kerselaers W.
Int J
Neuropsychopharmacol .
2010 May 12:1-11. [Epub ahead of print] Abilify:
20459883 [Abilify - as supplied by publisher] Related
Abilify Citations
Gateways to clinical trials.
Tomillero A, Moral MA.
Methods Find Exp
Clin Pharmacol .
2010 Apr;32(3):193-215. Abilify:
20448862 [Abilify - in process] Related
Abilify Citations
Rapid response to antipsychotic treatment on
psychotic prodrome: implications from a case series.
Liu CC, Sheu YH, Wu SY, Lai MC, Hwu HG.
Psychiatry Clin
Neurosci .
2010 Apr;64(2):202-6. Abilify: 20447014
[Abilify - in process] Related
Abilify Citations
The effect of metformin on anthropometrics and
insulin resistance in patients receiving atypical antipsychotic agents: a
meta-analysis.
Ehret M, Goethe J, Lanosa M, Coleman CI.
J Clin Psychiatry .
2010 Apr 6. [Epub ahead of print] Abilify:
20441727 [Abilify - as supplied by publisher] Related
Abilify Citations
Pharmacotherapy of Bipolar Disorder in Children and
Adolescents: Recent Progress.
Pfeifer JC, Kowatch RA, Delbello MP.
CNS Drugs .
2010 May 4. doi: 10.2165/11533110-000000000-00000. [Epub ahead of print] Abilify:
20441242 [Abilify - as supplied by publisher] Related
Abilify Citations
Aripiprazole improves social interaction in
Taiwanese children with pervasive developmental disorder.
Huang SC, Tsai SJ, Yang HJ.
Chang Gung Med J .
2010 Mar-Apr;33(2):211-5. Abilify:
20438675 [Abilify - in process] Free Article Related
Abilify Citations
Assessment of safety, tolerability and effectiveness
of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week,
open-label extension following a 6-week double-blind study.
Vieta E, Owen R, Baudelet C, McQuade RD, Sanchez R, Marcus RN.
Curr Med Res Opin .
2010 Jun;26(6):1485-96. Abilify:
20429835 [Abilify - in process] Related
Abilify Citations
Efficacy, safety and tolerability of Symbyax for
acute-phase management of treatment-resistant depression.
Bobo
WV ,
Shelton
Expert Rev Neurother .
2010 May;10(5):651-70. Abilify: 20420487
[Abilify - in process] Related
Abilify Citations
Effectiveness of aripiprazole in a patient with
presumed idiopathic Parkinson's disease and chronic paranoid schizophrenia.
Fujino J, Tanaka H, Taniguchi N, Tabushi K.
Psychiatry Clin
Neurosci .
2010 Feb;64(1):108-9. No abstract available.
Abilify: 20416032 [Abilify - in process] Related
Abilify Citations
Trial of aripiprazole in the treatment of
first-episode schizophrenia.
Lee HY, Ham BJ, Kang RH, Paik JW, Hahn SW, Lee MS, Lee MS.
Psychiatry Clin
Neurosci .
2010 Feb;64(1):38-43. Abilify: 20416024
[Abilify - in process] Related
Abilify Citations
Restless leg syndrome associated with olanzapine: a
case series.
Aggarwal S, Dodd S, Berk M.
Curr Drug Saf .
2010 Apr;5(2):129-31. Abilify: 20406161
[Abilify - in process] Related
Abilify Citations
Compliance with Atypical Antipsychotic Triage
Guidelines by Texas Poison Centers.
Forrester
MB .
J Med Toxicol .
2010 Apr 17. [Epub ahead of print] Abilify:
20401557 [Abilify - as supplied by publisher] Related
Abilify Citations
Systematic reviews of assessment measures and
pharmacologic treatments for agitation.
Zeller SL, Rhoades RW.
Clin Ther .
2010 Mar;32(3):403-25. Abilify: 20399981
[Abilify - in process] Related
Abilify Citations
Aripiprazole monotherapy in a patient with major
depressive disorder.
Yokoyama Y, Kitamura H, Someya T.
Prog
Neuropsychopharmacol Biol Psychiatry . 2010 Apr 14. [Epub ahead
of print] No abstract available.
Abilify: 20398715
[Abilify - as supplied by publisher] Related
Abilify Citations
Potential control of antipsychotic-induced
hyperprolactinemia and obesity in children and adolescents by aripiprazole.
Lian J, Huang XF, Pai N, Deng C.
Prog
Neuropsychopharmacol Biol Psychiatry . 2010 Apr 8. [Epub ahead
of print] No abstract available.
Abilify: 20381569
[Abilify - as supplied by publisher] Related
Abilify Citations
Effects of repeated and acute aripiprazole or
haloperidol treatment on dopamine synthesis in the dorsal striatum of young
rats: comparison to adult rats.
Der-Ghazarian T, Charntikov S, Varela FA, Crawford CA, McDougall SA.
J Neural Transm .
2010 May;117(5):573-83. Epub 2010 Apr 6. Abilify:
20372943 [Abilify - in process] Related
Abilify Citations
Optimization of aripiprazole synthesis.
Leś A, Badowska-Rosłonek K, Łaszcz M, Kamieńska-Duda A, Baran P, Kaczmarek Ł.
Acta Pol Pharm .
2010 Mar-Apr;67(2):151-7. Abilify:
20369792 [Abilify - indexed for MEDLINE] Related
Abilify Citations
Aripiprazole Improves Depressive Symptoms and
Immunological Response to Antiretroviral Therapy in an HIV-Infected Subject with
Resistant Depression.
Cecchelli C, Grassi G, Pallanti S.
Case Report Med .
2010;2010:836214. Epub 2010 Mar 30. Abilify:
20369069 [Abilify - in process] Free PMC Article Free
text Related
Abilify Citations
Mixed episodes with psychotic features.
Chou JC.
CNS Spectr .
2009 Nov;14(11 Suppl 11):6-8; discussion 12-4. Review. No abstract available.
Abilify: 20173694 [Abilify - indexed for MEDLINE] Related
Abilify Citations
Antipsychotic treatments for the elderly: efficacy
and safety of aripiprazole.
Kohen I, Lester PE, Lam S.
Neuropsychiatr Dis
Treat .
2010 Mar 24;6:47-58. Abilify: 20361061
[Abilify - in process] Free
PMC Article Free
text Related
Abilify Citations
D2 receptor occupancy in conscious rat brain is not
significantly distinguished with [(3)H]-MNPA, [(3)H]-(+)-PHNO and
[(3)H]-raclopride.
Peng T, Zysk J, Dorff P, Elmore CS, Ström P, Malmquist J, Ding M, Tuke D,
Werkheiser J, Widzowski D, Mrzljak L, Maier D.
Synapse .
2010 Mar 22. [Epub ahead of print] Abilify: 20340171 [Abilify -
as supplied by publisher] Related
Abilify Citations
Effect of aripiprazole on cognition in the treatment
of patients with schizophrenia.
Riedel M, Spellmann I, Schennach-Wolff R, Musil R, Dehning S, Cerovecki A,
Opgen-Rhein M, Matz J, Seemüller F, Obermeier M, Severus E, Engel RR, Müller N,
Möller HJ.
Pharmacopsychiatry .
2010 Mar;43(2):50-7. Epub 2009 Dec 10. Abilify:
20336597 [Abilify - in process] Related
Abilify Citations
Antipsychotic drug action on SREBPs-related
lipogenesis and cholesterogenesis in primary rat hepatocytes.
Lauressergues E, Staels B, Valeille K, Majd Z, Hum DW, Duriez P, Cussac D.
Naunyn Schmiedebergs
Arch Pharmacol .
2010 May;381(5):427-39. Epub 2010 Mar 24. Abilify:
20333360 [Abilify - in process] Related
Abilify Citations
Aripiprazole-induced gray matter growth in a patient
with major depressive disorder with panic disorder.
Lai CH.
J Clin Psychiatry .
2010 Mar;71(3):360-2. No abstract available.
Abilify: 20331938 [Abilify - indexed for MEDLINE] Related
Abilify Citations
Advances in the pharmacological management of
Huntington's disease.
Frank S, Jankovic J.
Drugs .
2010 Mar 26;70(5):561-71. doi: 10.2165/11534430-000000000-00000. Abilify:
20329804 [Abilify - in process] Related
Abilify Citations
Aripiprazole augmentation for the treatment of an
adolescent with posttraumatic stress disorder.
Yeh CC, Chou JY, Hsieh MH, Chen VC.
Prog
Neuropsychopharmacol Biol Psychiatry . 2010 May 30;34(4):722-3.
Epub 2010 Mar 16. No abstract available.
Abilify: 20298737 [Abilify - in process] Related
Abilify Citations
Olanzapine versus other atypical antipsychotics for
schizophrenia.
Komossa K, Rummel-Kluge C, Hunger H, Schmid F, Schwarz S, Duggan L, Kissling W,
Leucht S.
Cochrane Database
Syst Rev .
2010 Mar 17;3:CD006654. Review. Abilify:
20238348 [Abilify - indexed for MEDLINE] Related
Abilify Citations
Pharmacotherapies for alcoholism: the old and the
new.
Olive MF.
CNS Neurol Disord
Drug Targets .
2010 Mar 1;9(1):2-4. Abilify: 20232494
[Abilify - in process] Related
Abilify Citations
Favourable results in treatment-resistant
schizophrenic patients under combination of aripiprazole with clozapine.
Mossaheb N, Spindelegger C, Asenbaum S, Fischer P, Barnas C.
World J Biol
Psychiatry .
2010 Mar;11(2 Pt 2):502-5. Abilify:
20218805 [Abilify - in process] Related
Abilify Citations
Different patterns of longitudinal changes in plasma
levels of catecholamine metabolites and brain-derived neurotrophic factor after
administration of atypical antipsychotics in first episode untreated
schizophrenic patients.
Yoshimura R, Ueda N, Hori H, Ikenouchi-Sugita A, Umene-Nakano W, Nakamura J.
World J Biol
Psychiatry .
2010 Mar;11(2 Pt 2):256-61. Abilify:
20218790 [Abilify - in process] Related
Abilify Citations
Clinical use of aripiprazole in patients with
schizophrenia: A real-life setting results from the German Postmarketing
Surveillance Study.
Messer T, Schmauss M, Spevakne-Goeroecs T, Kungel M, Ebrecht M, Werner C, Modell
S.
World J Biol
Psychiatry .
2010 Mar;11(2 Pt 2):231-8. Abilify:
20218786 [Abilify - in process] Related
Abilify Citations
Second-generation antipsychotics cause weight gain
in youths.
[No authors listed]
Harv Ment Health
Lett .
2010 Jan;26(7):7. No abstract available.
Abilify: 20217902 [Abilify - indexed for MEDLINE] Related
Abilify Citations
Symptomatic bradycardia with oral aripiprazole and
oral ziprasidone.
Snarr BS, Phan SV, Garner A, VandenBerg AM,
Barth
KS .
Ann Pharmacother .
2010 Apr;44(4):760-3. Epub 2010 Mar 9. Abilify:
20215494 [Abilify - in process] Related
Abilify Citations
Drug-induced Pisa syndrome associated with
aripiprazole during clozapine treatment.
Chen HK, Wu BJ, Shao CH.
Prog
Neuropsychopharmacol Biol Psychiatry . 2010 May 30;34(4):707-8.
Epub 2010 Mar 6. No abstract available.
Abilify: 20211216 [Abilify - in process] Related
Abilify Citations
Fluvoxamine for aripiprazole-associated akathisia in
patients with schizophrenia: a potential role of sigma-1 receptors.
Furuse T, Hashimoto K.
Ann Gen Psychiatry .
2010 Mar 6;9:11. Abilify: 20205742 [Abilify -
in process] Free
PMC Article Free
text Related
Abilify Citations
Aripiprazole: a drug with a novel mechanism of
action and possible efficacy for alcohol dependence.
Vergne
DE ,
Anton RF.
CNS Neurol Disord
Drug Targets .
2010 Mar 1;9(1):50-4. Abilify: 20201815
[Abilify - in process] Related
Abilify Citations
Early intervention with second-generation
antipsychotics in first-episode psychosis: results of an 8-week naturalistic
study.
Josiassen RC, Shaughnessy RA, Filymer DM, Donohue AM, Kacso M, Finkel N, Curtis
J, Audino B, Skuban N.
Early Interv
Psychiatry .
2010 Feb;4(1):57-63. Abilify: 20199481
[Abilify - in process] Related
Abilify Citations
Changes in medication practices for hospitalized
psychiatric patients: 2009 versus 2004.
Centorrino F, Ventriglio A, Vincenti A, Talamo A, Baldessarini RJ.
Hum Psychopharmacol .
2010 Mar;25(2):179-86. Abilify: 20196186
[Abilify - in process] Related
Abilify Citations
Aripiprazole as adjunct to a mood stabilizer and
citalopram in bipolar depression: a randomized placebo-controlled pilot study.
Quante A, Zeugmann S, Luborzewski A, Schommer N, Langosch J, Born C, Anghelescu
I, Wolf J.
Hum Psychopharmacol .
2010 Mar;25(2):126-32. Abilify: 20196183
[Abilify - in process] Related
Abilify Citations
Neurocognition and its influencing factors in the
treatment of schizophrenia-effects of aripiprazole, olanzapine, quetiapine and
risperidone.
Riedel M, Schennach-Wolff R, Musil R, Dehning S, Cerovecki A, Opgen-Rhein M,
Matz J, Seemüller F, Obermeier M, Engel RR, Müller N, Möller HJ, Spellmann I.
Hum Psychopharmacol .
2010 Mar;25(2):116-25. Abilify: 20196179
[Abilify - in process] Related
Abilify Citations
Switching schizophrenia patients from typical
neuroleptics to aripiprazole: effects on working memory dependent functional
activation.
Schlagenhauf F, Dinges M, Beck A, Wüstenberg T, Friedel E, Dembler T, Sarkar R,
Wrase J, Gallinat J, Juckel G, Heinz A.
Schizophr Res .
2010 May;118(1-3):189-200. Epub 2010 Feb 26. Abilify:
20189356 [Abilify - in process] Related
Abilify Citations
Aripiprazole in anorexia nervosa and low-weight
bulimia nervosa: Case reports.
Trunko ME, Schwartz TA, Duvvuri V, Kaye WH.
Int J Eat Disord .
2010 Feb 22. [Epub ahead of print] Abilify:
20186719 [Abilify - as supplied by publisher] Related
Abilify Citations
Identification of molecular targets associated with
ethanol toxicity and implications in drug development.
Wang LL, Yang AK, He SM, Liang J, Zhou ZW, Li Y, Zhou SF.
Curr Pharm Des .
2010;16(11):1313-55. Abilify: 20184550
[Abilify - in process] Related
Abilify Citations
[Disappearance of paroxysmal perceptual alteration
by switching to aripiprazole in a schizophrenic patient]
Kondo M, Ikejiri Y, Hanatani T, Sumi N.
Seishin Shinkeigaku
Zasshi .
2010;112(1):23-30. Japanese.
Abilify: 20184237 [Abilify - indexed for MEDLINE] Related
Abilify Citations
Pathological gambling and compulsive eating
associated with aripiprazole.
Roxanas MG.
Aust N Z J
Psychiatry .
2010 Mar;44(3):291. No abstract available.
Abilify: 20180730 [Abilify - in process] Related
Abilify Citations
Benefits of switching women schizophrenic patients
to aripiprazole: a case study and brief review of the literature.
Kuloglu M, Ekinci O, Albayrak Y, Caykoylu A.
Arch Womens Ment
Health .
2010 Feb 24. [Epub ahead of print] Abilify:
20179976 [Abilify - as supplied by publisher] Related
Abilify Citations
Effect of aripiprazole, risperidone, and olanzapine
on the acoustic startle response in Japanese chronic schizophrenia.
Kishi T, Moriwaki M, Kitajima T, Kawashima K, Okochi T, Fukuo Y, Furukawa O,
Naitoh H, Fujita K, Iwata N.
Psychopharmacology
(Berl) .
2010 Apr;209(2):185-90. Epub 2010 Feb 23. Abilify:
20177883 [Abilify - in process] Related
Abilify Citations
Costs and outcomes associated with an aripiprazole
add-on or switching open-label study in psychosis.
Aitchison KJ, Mir A, Shivakumar K, McAllister VD, O'Keane V, McCrone P.
J Psychopharmacol .
2010 Feb 22. [Epub ahead of print] Abilify:
20176773 [Abilify - as supplied by publisher] Related
Abilify Citations
Improvement of restless legs syndrome and
trichotillomania with aripiprazole.
Virit O, Selek S, Savas HA, Kokaçya H.
J Clin Pharm Ther .
2009 Dec;34(6):723-5. Abilify: 20175807
[Abilify - indexed for MEDLINE] Related
Abilify Citations
Changes in positive and negative syndrome
scale-derived hostility factor in adolescents with schizophrenia treated with
aripiprazole: post hoc analysis of randomized clinical trial data.
Robb AS, Carson WH, Nyilas M, Ali M, Forbes RA, Iwamoto T, Assunção-Talbott S,
Whitehead R, Pikalov A.
J Child Adolesc
Psychopharmacol .
2010 Feb;20(1):33-8. Abilify: 20166794
[Abilify - indexed for MEDLINE] Related
Abilify Citations
Aripiprazole, hypertension, and confusion.
Pitchot W, Ansseau M.
J Neuropsychiatry
Clin Neurosci .
2010 Winter;22(1):123.E33. No abstract available.
Abilify: 20160240 [Abilify - indexed for MEDLINE] Related
Abilify Citations
Predictors of early worsening after switch to
aripiprazole: a randomized, controlled, open-label study.
Pae CU, Chiesa A, Mandelli L, Patkar AA, Gibiino S, Serretti A.
Clin Drug Investig .
2010;30(3):187-93. doi: 10.2165/11533060-000000000-00000. Abilify:
20155991 [Abilify - indexed for MEDLINE] Related
Abilify Citations
Aripiprazole for the maintenance treatment of
bipolar I disorder: A review.
McIntyre RS.
Clin Ther .
2010;32 Suppl 1:S32-8. Review. Abilify:
20152551 [Abilify - indexed for MEDLINE] Related
Abilify Citations
Aripiprazole in schizophrenia and schizoaffective
disorder: A review.
Stip E, Tourjman V.
Clin Ther .
2010;32 Suppl 1:S3-20. Review. Abilify:
20152550 [Abilify - indexed for MEDLINE] Related
Abilify Citations
The role of aripiprazole in Canada: A review of
clinical and drug discontinuation data. Foreword.
McIntyre RS.
Clin Ther .
2010;32 Suppl 1:S1-2. No abstract available.
Abilify: 20152548 [Abilify - indexed for MEDLINE] Related
Abilify Citations
Evidence-based use of second-generation
antipsychotics in a state Medicaid pediatric population, 2001-2005.
Pathak P, West D, Martin BC, Helm ME,
Henderson
Psychiatr Serv .
2010 Feb;61(2):123-9. Abilify: 20123816
[Abilify - indexed for MEDLINE] Related
Abilify Citations
Use of aripiprazole in clozapine induced enuresis:
report of two cases.
Lee MJ, Kim CE.
J Korean Med Sci .
2010 Feb;25(2):333-5. Epub 2010 Jan 19. Abilify:
20119596 [Abilify - indexed for MEDLINE] Free
PMC Article Free
text Related
Abilify Citations
The association between class of antipsychotic and
rates of hospitalization: results of a retrospective analysis of data from the
2005 Medicare current beneficiary survey.
Kennedy J, Tien YY, Cohen LJ, Sclar DA, Liu D, Blodgett EG, Engle J.
Clin Ther .
2009 Dec;31(12):2931-9. Abilify:
20110033 [Abilify - indexed for MEDLINE] Related
Abilify Citations
[Aripiprazole-induced stuttering treated with
risperidone.]
Rocha FF.
Rev Bras Psiquiatr .
2009 Dec;31(4):388. Portuguese. No abstract available.
Abilify: 20098832 [Abilify - in process] Free
Article Related
Abilify Citations
Safety and Tolerability of Adjunctive Aripiprazole
in Major Depressive Disorder: A Pooled Post Hoc Analysis (studies CN138-139 and
CN138-163).
Nelson JC, Thase ME, Trivedi MH, Fava M, Han J, Van Tran Q, Pikalov A, Qi Y,
Carlson BX, Marcus RN, Berman RM.
Prim Care Companion
J Clin Psychiatry .
2009;11(6):344-352. Abilify: 20098527
[Abilify - as supplied by publisher] Free PMC Article Free
text Related
Abilify Citations
Functional SNPs in Genes Encoding the 5-HT2A
Receptor Modify the Affinity and Potency of Several Atypical Antipsychotic
Drugs.
Davies MA, Conley Y, Roth BL.
Biol Res Nurs .
2010 Jan 21. [Epub ahead of print] Abilify:
20097665 [Abilify - as supplied by publisher] Related
Abilify Citations
Identification of selected therapeutic agents as
inhibitors of carboxylesterase 1: potential sources of metabolic drug
interactions.
Zhu HJ, Appel DI, Peterson YK, Wang Z, Markowitz JS.
Toxicology .
2010 Apr 11;270(2-3):59-65. Epub 2010 Jan 25. Abilify:
20097249 [Abilify - indexed for MEDLINE] Related
Abilify Citations
The 5-HT(7) receptor as a mediator and modulator of
antidepressant-like behavior.
Sarkisyan G, Roberts AJ, Hedlund PB.
Behav Brain Res .
2010 May 1;209(1):99-108. Epub 2010 Jan 25. Abilify:
20097233 [Abilify - indexed for MEDLINE] Related
Abilify Citations
Gateways to clinical trials.
Tomillero A, Moral MA.
Methods Find Exp
Clin Pharmacol .
2009 Nov;31(9):597-633. Abilify:
20094643 [Abilify - indexed for MEDLINE] Related
Abilify Citations
Cariprazine (RGH-188), a dopamine D(3)
receptor-preferring, D(3)/D(2) dopamine receptor antagonist-partial agonist
antipsychotic candidate: in vitro and neurochemical profile.
Kiss B, Horváth A, Némethy Z, Schmidt E, Laszlovszky I, Bugovics G, Fazekas K,
Hornok K, Orosz S, Gyertyán I, Agai-Csongor E, Domány G, Tihanyi K, Adham N,
Szombathelyi Z.
J Pharmacol Exp Ther .
2010 Apr;333(1):328-40. Epub 2010 Jan 21. Abilify:
20093397 [Abilify - indexed for MEDLINE] Related
Abilify Citations
Zotepine versus other atypical antipsychotics for
schizophrenia.
Komossa K, Rummel-Kluge C, Hunger H, Schmid F, Schwarz S, Kissling W, Leucht S.
Cochrane Database
Syst Rev .
2010 Jan 20;(1):CD006628. Review. Abilify:
20091601 [Abilify - indexed for MEDLINE] Related
Abilify Citations
Quetiapine versus other atypical antipsychotics for
schizophrenia.
Komossa K, Rummel-Kluge C, Schmid F, Hunger H, Schwarz S, Srisurapanont M,
Kissling W, Leucht S.
Cochrane Database
Syst Rev .
2010 Jan 20;(1):CD006625. Review. Abilify:
20091600 [Abilify - indexed for MEDLINE] Related
Abilify Citations
Amisulpride versus other atypical antipsychotics for
schizophrenia.
Komossa K, Rummel-Kluge C, Hunger H, Schmid F, Schwarz S, Silveira da Mota Neto
JI, Kissling W, Leucht S.
Cochrane Database
Syst Rev .
2010 Jan 20;(1):CD006624. Review. Abilify:
20091599 [Abilify - indexed for MEDLINE] Related
Abilify Citations
Therapeutic options for treatment-resistant
depression.
Shelton
RC, Osuntokun O, Heinloth AN, Corya SA.
CNS Drugs .
2010 Feb 1;24(2):131-61. doi: 10.2165/11530280-000000000-00000. Review. Abilify:
20088620 [Abilify - indexed for MEDLINE] Related
Abilify Citations
Effects of aripiprazole on MK-801-induced prepulse
inhibition deficits and mitogen-activated protein kinase signal transduction
pathway.
Ishii D, Matsuzawa D, Kanahara N, Matsuda S, Sutoh C, Ohtsuka H, Nakazawa K,
Kohno M, Hashimoto K, Iyo M, Shimizu E.
Neurosci Lett .
2010 Feb 26;471(1):53-7. Epub 2010 Jan 18. Abilify:
20083164 [Abilify - indexed for MEDLINE] Related
Abilify Citations
Neuroleptic malignant syndrome with the addition of
aripiprazole to clozapine.
Dassa D, Drai-Moog D, Samuelian JC.
Prog
Neuropsychopharmacol Biol Psychiatry . 2010 Mar 17;34(2):427-8.
Epub 2010 Jan 17. No abstract available.
Abilify: 20080143 [Abilify - indexed for MEDLINE] Related
Abilify Citations
Treatment with aripiprazole for hyperprolactinemia
induced by pituitary microadenoma in a bipolar I disorder patient.
Chen ST ,
Hsiao YL.
J Clin
Psychopharmacol .
2010 Feb;30(1):78-80. No abstract available.
Abilify: 20075655 [Abilify - indexed for MEDLINE] Related
Abilify Citations
Aripiprazole induced acute dystonia after
discontinuation of a stimulant medication.
McLaren JL, Cauble S, Barnett RJ.
J Clin
Psychopharmacol .
2010 Feb;30(1):77-8. No abstract available.
Abilify: 20075654 [Abilify - indexed for MEDLINE] Related
Abilify Citations
Priapism associated with antipsychotics: role of
alpha1 adrenoceptor affinity.
Andersohn F, Schmedt N, Weinmann S, Willich SN, Garbe E.
J Clin
Psychopharmacol .
2010 Feb;30(1):68-71. Abilify: 20075651
[Abilify - indexed for MEDLINE] Related
Abilify Citations
The risk of death among adult participants in trials
of antipsychotic drugs in schizophrenia.
Isaac M, Koch A.
Eur
Neuropsychopharmacol .
2010 Mar;20(3):139-45. Epub 2010 Jan 6. Abilify:
20053539 [Abilify - in process] Related
Abilify Citations
Co-operativity in agonist binding at the D2 dopamine
receptor: evidence from agonist dissociation kinetics.
Kara E, Lin H, Strange PG.
J Neurochem .
2010 Mar;112(6):1442-53. Epub 2009 Dec 24. Abilify:
20050980 [Abilify - indexed for MEDLINE] Related
Abilify Citations
Metabolic testing rates in 3 state Medicaid programs
after FDA warnings and ADA/APA recommendations for second-generation
antipsychotic drugs.
Morrato EH, Druss B, Hartung DM, Valuck RJ, Allen R, Campagna E, Newcomer JW.
Arch Gen Psychiatry .
2010 Jan;67(1):17-24. Abilify: 20048219
[Abilify - indexed for MEDLINE] Related
Abilify Citations
Efficacy of the atypical antipsychotic aripiprazole
in d-amphetamine-based preclinical models of mania.
Mavrikaki M, Nomikos GG, Panagis G.
Int J
Neuropsychopharmacol .
2010 May;13(4):541-8. Epub 2010 Jan 5. Abilify:
20047715 [Abilify - in process] Related
Abilify Citations
Pharmacotherapy for borderline personality disorder:
Cochrane systematic review of randomised trials.
Lieb K, Völlm B, Rücker G, Timmer A, Stoffers JM.
Br J Psychiatry .
2010 Jan;196(1):4-12. Review. Abilify:
20044651 [Abilify - indexed for MEDLINE] Related
Abilify Citations
Treatment of psychotic symptoms in bipolar disorder
with aripiprazole monotherapy: a meta-analysis.
Fountoulakis KN, Gonda X, Vieta E, Schmidt F.
Ann Gen Psychiatry .
2009 Dec 31;8:27. Abilify: 20043829 [Abilify -
in process] Free
PMC Article Free
text Related
Abilify Citations
Aripiprazole in children and adolescents with
Tourette's disorder: an open-label safety and tolerability study.
Lyon GJ, Samar S, Jummani R, Hirsch S, Spirgel A, Goldman R, Coffey BJ.
J Child Adolesc
Psychopharmacol .
2009 Dec;19(6):623-33. Abilify: 20035580
[Abilify - indexed for MEDLINE] Related
Abilify Citations
The effect of dopamine partial agonists on the
nicotine dependency in patients with schizophrenia.
Kim SH, Han DH, Joo SY, Min KJ.
Hum Psychopharmacol .
2010 Mar;25(2):187-90. Abilify: 20033907
[Abilify - in process] Related
Abilify Citations
Aripiprazole and adolescent schizophrenia: a simple
neuroleptic. No comparison with standard neuroleptic in adolescents.
[No authors listed]
Prescrire Int .
2009 Dec;18(104):251. No abstract available.
Abilify: 20025091 [Abilify - indexed for MEDLINE] Related
Abilify Citations
Evaluation of akathisia in patients with
schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc
analysis of pooled data from short- and long-term aripiprazole trials.
Kane JM, Barnes TR, Correll CU, Sachs G, Buckley P, Eudicone J, McQuade R, Van
Tran Q, Pikalov A 3rd, Assunção-Talbott S.
J Psychopharmacol .
. [Epub ahead of print] Abilify: 20008446
[Abilify - as supplied by publisher] Related
Abilify Citations
Pediatric bipolar disorder.
Carbray MJ, McGuinness T.
J Psychosoc Nurs
Ment Health Serv .
2009 Dec;47(12):22-6. doi: 10.3928/02793695-20091103-02. Abilify:
20000279 [Abilify - indexed for MEDLINE] Related
Abilify Citations
Managing partial response or nonresponse: switching,
augmentation, and combination strategies for major depressive disorder.
Papakostas GI.
J Clin Psychiatry .
2009;70 Suppl 6:16-25. Review. Abilify:
19922740 [Abilify - indexed for MEDLINE] Related
Abilify Citations
Effects of a positive allosteric modulator of mGluR5
ADX47273 on conditioned avoidance response and PCP-induced hyperlocomotion in
the rat as models for schizophrenia.
Schlumberger C, Pietraszek M, Gravius A, Danysz W.
Pharmacol Biochem
Behav .
2010 Mar;95(1):23-30. Epub 2009 Dec 5. Abilify:
19995568 [Abilify - in process] Related
Abilify Citations
